Gurugram, India

Jyoti Srivastava

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Sun Pharmaceutical Industries Limited, Ranbaxy Laboratories, Inc.. Active years: 2015-2017.

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2015-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Jyoti Srivastava

Introduction

Jyoti Srivastava is a notable inventor based in Gurgaon, India. He has made significant contributions to the field of pharmaceuticals, particularly in developing topical compositions for medical treatments. With a total of 3 patents to his name, his work focuses on improving the efficacy of treatments for burn injuries and microbial infections.

Latest Patents

One of his latest patents is a topical pharmaceutical composition comprising nanonized silver sulfadiazine. This invention is designed for the treatment of burns and microbial infections in both humans and animals. The composition includes 0.1% w/w to 1.0% w/w of silver sulfadiazine, an antimicrobial drug, and 0.2% w/w of chlorhexidine gluconate, an antiseptic. The unique aspect of this formulation is that silver sulfadiazine is presented in a nanonized form, enhancing its effectiveness.

Career Highlights

Jyoti has worked with prominent companies in the pharmaceutical industry, including Sun Pharmaceutical Industries Limited and Ranbaxy Laboratories, Inc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Some of his notable coworkers include Vinod Kumar Arora and Neeta Gupta, who have collaborated with him on various projects throughout his career.

Conclusion

Jyoti Srivastava's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare solutions. His patents reflect a dedication to advancing treatment options for patients, particularly in the area of burn care and infection management.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…